Recent discussions surrounding GLP-1 medications, particularly Ozempic, have brought attention to unusual cosmetic side effects, including terms like “Ozempic mouth” and “Ozempic feet.” These side effects typically manifest as excessive wrinkles or sagging skin resulting from rapid weight loss, a byproduct of the medications rather than the medications themselves.
Experts in the field suggest that significant weight loss can lead to changes in body appearance due to the loss of fat and muscle mass. They emphasize that while these effects may be concerning, they are primarily cosmetic and not indicative of health risks. To mitigate these side effects, healthcare professionals recommend lifestyle modifications such as increasing dietary protein, engaging in resistance training, and adopting a slower weight loss approach.
Healthcare providers underline the importance of a supportive team for individuals considering weight loss medications. They advise that weight loss should not be rushed and emphasize the need for a comprehensive plan that includes nutritional and exercise strategies tailored to individual needs.
Additionally, the medications Ozempic and Wegovy, both containing semaglutide, are designed to suppress appetite, aiding weight loss and management. They are FDA-approved for different uses—Ozempic for type 2 diabetes and Wegovy for weight management. Other injectable medications like Mounjaro and Zepbound also address similar issues but contain different active ingredients.
Healthcare experts encourage those using weight loss medications to remain vigilant about their lifestyle choices and to work closely with medical professionals to develop strategies for safely achieving and maintaining weight loss goals. This includes planning for a transition off the medications once desired outcomes are achieved, ensuring a sustainable approach to health.